Global healthcare company Hekto Healthcare has introduced its premium probiotic brand, 'De Simone,' featuring a high-potency capsule that guarantees 100 billion CFU of probiotics per capsule.
According to Hekto Healthcare, the new product will be officially launched on October 12, with pre-sales starting today on the De Simone official site. The pre-sale is limited to 1,000 units and offers discounts of up to 40%. Orders will be shipped sequentially starting from the official launch date.
The De Simone Premium Capsule is designed for easy consumption, with one capsule providing 100 billion CFU of probiotics. Hekto Healthcare aims to strengthen its direct-to-consumer (D2C) strategy with this launch, expanding consumer engagement through its official site by providing product information and unique purchasing experiences, including pre-sales and exclusive benefits.
Kim Seok-jin, CEO of Hekto Healthcare, stated, "We will continue to expand our product portfolio based on accumulated research and technology, considering the diverse health management needs and convenience of consumers."
Meanwhile, De Simone was recently voted the top brand in the probiotics category at the '2026 Brand of the Year Awards' through a public consumer vote. This event, hosted by the Korean Consumer Brand Committee, allows consumers to participate in online and phone surveys to select representative brands in various categories.
De Simone is manufactured based on the 'De Simone Formulation' developed by probiotic researcher Claudio De Simone. The formulation has been validated through 469 international academic papers, including those published in SCI-level journals. It is patented in 15 countries and distributed in 40 countries, including the United States and Europe.
In South Korea, it received individual recognition from the Ministry of Food and Drug Safety in 2009 for its functionality in helping to regulate intestinal immunity and promote gut health.
According to Hekto Healthcare, the new product will be officially launched on October 12, with pre-sales starting today on the De Simone official site. The pre-sale is limited to 1,000 units and offers discounts of up to 40%. Orders will be shipped sequentially starting from the official launch date.
The De Simone Premium Capsule is designed for easy consumption, with one capsule providing 100 billion CFU of probiotics. Hekto Healthcare aims to strengthen its direct-to-consumer (D2C) strategy with this launch, expanding consumer engagement through its official site by providing product information and unique purchasing experiences, including pre-sales and exclusive benefits.
Kim Seok-jin, CEO of Hekto Healthcare, stated, "We will continue to expand our product portfolio based on accumulated research and technology, considering the diverse health management needs and convenience of consumers."
Meanwhile, De Simone was recently voted the top brand in the probiotics category at the '2026 Brand of the Year Awards' through a public consumer vote. This event, hosted by the Korean Consumer Brand Committee, allows consumers to participate in online and phone surveys to select representative brands in various categories.
De Simone is manufactured based on the 'De Simone Formulation' developed by probiotic researcher Claudio De Simone. The formulation has been validated through 469 international academic papers, including those published in SCI-level journals. It is patented in 15 countries and distributed in 40 countries, including the United States and Europe.
In South Korea, it received individual recognition from the Ministry of Food and Drug Safety in 2009 for its functionality in helping to regulate intestinal immunity and promote gut health.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.